Tokat, Ü.M.; Adibi, A.; Aydın, E.; Özgü, E.; Bilgiç, Ş.N.; Tutar, O.; Özbek Doğançay, M.; Demiray, İ.; Demiray, M.
Personalized Immunotherapy Achieves Complete Response in Metastatic Adenoid Cystic Carcinoma Despite Lack of Conventional Biomarkers. Curr. Oncol. 2024, 31, 5838-5849.
https://doi.org/10.3390/curroncol31100434
AMA Style
Tokat ÜM, Adibi A, Aydın E, Özgü E, Bilgiç ŞN, Tutar O, Özbek Doğançay M, Demiray İ, Demiray M.
Personalized Immunotherapy Achieves Complete Response in Metastatic Adenoid Cystic Carcinoma Despite Lack of Conventional Biomarkers. Current Oncology. 2024; 31(10):5838-5849.
https://doi.org/10.3390/curroncol31100434
Chicago/Turabian Style
Tokat, Ünal Metin, Ashkan Adibi, Esranur Aydın, Eylül Özgü, Şevval Nur Bilgiç, Onur Tutar, Merve Özbek Doğançay, İrem Demiray, and Mutlu Demiray.
2024. "Personalized Immunotherapy Achieves Complete Response in Metastatic Adenoid Cystic Carcinoma Despite Lack of Conventional Biomarkers" Current Oncology 31, no. 10: 5838-5849.
https://doi.org/10.3390/curroncol31100434
APA Style
Tokat, Ü. M., Adibi, A., Aydın, E., Özgü, E., Bilgiç, Ş. N., Tutar, O., Özbek Doğançay, M., Demiray, İ., & Demiray, M.
(2024). Personalized Immunotherapy Achieves Complete Response in Metastatic Adenoid Cystic Carcinoma Despite Lack of Conventional Biomarkers. Current Oncology, 31(10), 5838-5849.
https://doi.org/10.3390/curroncol31100434
